News & Events

• November 3, 2016
  

  Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (Including Biological Products) in Neonates

  Ward RM, Benjamin D, Barrett JS, Allegaert K, Portman R, Davis JM, Turner MA, and the International Neonatal Consortium. Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (including Biological Products) in Neonates. Pediatric Research. 2017 Mar 1....
• September 29, 2016
  

  The International Neonatal Consortium: Collaborating to Advance Regulatory Science for Neonates

  Turner MA, Davis JM, McCune S, Bax R, Portman RJ, Hudson, LD. “The International Neonatal Consortium  Collaborating to Advance Regulatory Science for Neonates.” Pediatric Research 80(4): 462-463 (2016)....
• October 1, 2015
  

  Global Collaboration to Develop New and Existing Drugs for Neonates

  Davis JM, Turner MA. Global Collaboration to Develop New and Existing Drugs for Neonates. JAMA pediatrics. 2015 Oct;169(10):887–8....
• September 13, 2015
  

  Global Efforts to Accelerate the Development of Safe and Efficacious Therapies for Newborns

  Davis, Jonathan M. Global Efforts to Accelerate the Development of Safe and Efficacious Therapies for Newborns. American Academy of Pediatrics. Volume 5. Issue 2. 2015 Fall;20.

• August 7, 2015
  

  Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates

  Offringa M, Davis JM, Turner MA, Ward R, Bax R, Maldonado S, Sinha V, McCune SK, Zajicek A, Daniel K. Benjamin J, Bucci-Rechtweg C, Nelson RM. Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates. Therapeutic Innovation & Regulatory Science. 2015 Aug 7;...